Synopsys, Inc. (NASDAQ:SNPS) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Synopsys, Inc. (NASDAQ:SNPSGet Free Report) have earned an average rating of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $649.00.

A number of research firms have issued reports on SNPS. Mizuho assumed coverage on Synopsys in a research note on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 price target for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $640.00 target price on shares of Synopsys in a report on Thursday, December 5th. Berenberg Bank began coverage on shares of Synopsys in a research note on Tuesday, October 15th. They set a “buy” rating and a $660.00 price target on the stock. Wells Fargo & Company began coverage on Synopsys in a research note on Friday, November 22nd. They issued an “equal weight” rating and a $570.00 price objective for the company. Finally, Robert W. Baird lowered their target price on Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th.

Check Out Our Latest Analysis on SNPS

Synopsys Price Performance

SNPS stock opened at $494.43 on Friday. The company has a market cap of $75.95 billion, a P/E ratio of 34.05, a price-to-earnings-growth ratio of 3.41 and a beta of 1.08. Synopsys has a 1 year low of $457.52 and a 1 year high of $629.38. The stock’s fifty day moving average price is $530.72 and its 200-day moving average price is $541.02.

Institutional Trading of Synopsys

Several institutional investors have recently made changes to their positions in the business. Davidson Capital Management Inc. grew its holdings in Synopsys by 33,828.6% during the 3rd quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company’s stock valued at $2,405,000 after buying an additional 4,736 shares in the last quarter. Peloton Wealth Strategists grew its stake in Synopsys by 221.2% during the third quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company’s stock valued at $1,459,000 after acquiring an additional 1,984 shares in the last quarter. Swiss National Bank increased its holdings in Synopsys by 0.7% in the 3rd quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company’s stock valued at $230,306,000 after acquiring an additional 3,200 shares during the last quarter. Parnassus Investments LLC purchased a new stake in Synopsys in the 3rd quarter worth $633,469,000. Finally, Harvest Portfolios Group Inc. boosted its holdings in shares of Synopsys by 3.7% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company’s stock valued at $21,330,000 after purchasing an additional 1,496 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Company Profile

(Get Free Report

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Articles

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.